|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400089231 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-04 10:31:33 |
|
注册时间: Date of Registration: |
2024-09-04 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
晚期癌症患者营养相关症状管理循证应答自助系统的效果评价 |
|
Public title: |
Effects of an evidence-based response self-care system for advance cancer patients with nutrition impact symptoms |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
安宁疗护晚期癌症患者营养相关症状群变化规律及循证应答自助系统研究 |
|
Scientific title: |
A study on the changes of nutrition-related symptom clusters and evidence-based response self-help system in palliative care for patients with advanced cancer |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
林铮泷 |
研究负责人: |
肖惠敏 |
|
Applicant: |
Zhenglong Lin |
Study leader: |
Huimin Xiao |
|
申请注册联系人电话: Applicant telephone: |
+86 150 6001 0450 |
研究负责人电话:
Study leader's |
+86 138 6069 2061 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1093565104@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
huimin_xiao@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
福建省福州市学府北路1号 |
研究负责人通讯地址: |
福建省福州市学府北路1号 |
|
Applicant address: |
1 Xuefu North Road, Fuzhou, Fujian,China |
Study leader's address: |
1 Xuefu North Road, Fuzhou, Fujian,China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
福建医科大学 |
||
|
Applicant's institution: |
Fujian Medical University |
||
|
研究负责人所在单位: |
福建医科大学 |
||
|
Affiliation of the Leader: |
Fujian Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
福医伦理审字[2022]第91号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
福建医科大学生物医学研究伦理审查委员会 |
||
|
Name of the ethic committee: |
Biomedical Research Ethics Review Committee, Fujian Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-06-08 00:00:00 | ||
|
伦理委员会联系人: |
苏锦云 |
||
|
Contact Name of the ethic committee: |
Jinyun Su |
||
|
伦理委员会联系地址: |
福建医科大学上街校区行政办公楼C-415 |
||
|
Contact Address of the ethic committee: |
C-415, Administrative Building, Shangshang Campus, Fujian Medical University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 591 2286 2443 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
福建医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Fujian Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
福建省福州市学府北路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Xuefu North Road, Fuzhou, Fujian,China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
省科技厅 |
||||||||||||||||||||||
|
Source(s) of funding: |
Provincial science and technology Department |
||||||||||||||||||||||
|
研究疾病: |
晚期癌症 |
||||||||||||||||||||||
|
Target disease: |
Advanced cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
评价晚期癌症患者营养相关症状管理循证应答自助系统的效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
To evaluate the effectiveness of an evidence-based response self-care system for advanced cancer patients with nutrition impact symptoms. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
患者纳入标准:1.确诊为晚期癌症,且正在接受居家照护服务;2.年龄≥18岁;3.知晓疾病诊断及预后;4.无认知及交流障碍;5.拥有智能手机,能使用微信小程序。 家庭照顾者的纳入标准:1.年龄≥18岁;2.与癌症患者共同居住;3.承担照护责任的主要照顾者。 |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria for patients are: (a) diagnosed with advanced cancer and receiving home-based hospice care; (b) aged 18?years old or above; (c) aware of diagnosis and prognosis; (d) without verbal communication impairment or cognitive impairment; and (e) possessing a mobile communication device and able to communicate through WeChat software. The inclusion criteria for family caregivers are: (1) aged 18 or older; (2) living with a cancer patient; and (3) the main caregiver caring for the patient. |
||||||||||||||||||||||
|
排除标准: |
患者排除标准:1.病情迅速恶化(KPS评分<40分);2.接受其他营养干预。 家庭照顾者排除标准:1.既往患有精神疾病;2.存在认知障碍和沟通障碍。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria for patients: (1) having a cancer that was expected to progress rapidly (Karnofsky Performance Status Score lower than 40%); (2) receiving other nutrition interventions. Exclusion criteria for family caregivers: (1) with a history of mental illness; and (2) with a cognitive or communication disorder. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-09-20 00:00:00至 To 2025-10-20 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-09-20 00:00:00 至 To 2025-10-20 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由不参与本研究的课题组其他成员利用Research Randomizer网站(https://www.randomizer.org)产生一套随机数字序列。该序列含1-72个不重复的随机数字,然后将随机数字分别装入按顺序编码、密封、不透光的信封中,交给随机数字保管员。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The member of the research group who does not participate in this study will use the Research Randomizer (https://www.randomizer.org)to generate a set of random number sequence. The sequence contains 1-72 non repetitive random numbers, and then the random numbers are respectively put into sequentially encoded, sealed and light tight envelopes and handed over to the random number keeper. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
本研究对问卷调查员、资料分析员设盲。 |
|
Blinding: |
In this study, surveyors and data analysts will be blind. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
我们将以论文的形式公布实验方案,对有需要的原始数据的科研工作者,可以联系作者获得原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
We will publish the experimental plan in the form of a paper. For scientific researchers who need the original data, they can contact the author to obtain the original data. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
由经过专门培训的人员进行测量、采集数据以及建立数据库,为保证数据录入的准确性,所有数据均由双人录入,并采用SPSS软件进行数据处理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The measurement, data collection and database establishment will be carried out by trained professionals. In order to ensure the accuracy of data entry, all data wil be entered by two people, and SPSS software will be used for data processing. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |